These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 27553024)
1. Downregulation of paraoxonase 3 contributes to aggressive human hepatocellular carcinoma progression and associates with poor prognosis. Jin Y; Li Q; Qiu J; Zhao X; Zheng C; Lv S; Bai Y; Shan Y; Ye LC Tumour Biol; 2016 Oct; 37(10):14193-14203. PubMed ID: 27553024 [TBL] [Abstract][Full Text] [Related]
2. Ack1 overexpression promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Lei X; Li YF; Chen GD; Ou DP; Qiu XX; Zuo CH; Yang LY Oncotarget; 2015 Dec; 6(38):40622-41. PubMed ID: 26536663 [TBL] [Abstract][Full Text] [Related]
3. The suppressor of cytokine signaling 2 (SOCS2) inhibits tumor metastasis in hepatocellular carcinoma. Cui M; Sun J; Hou J; Fang T; Wang X; Ge C; Zhao F; Chen T; Xie H; Cui Y; Yao M; Li J; Li H Tumour Biol; 2016 Oct; 37(10):13521-13531. PubMed ID: 27465557 [TBL] [Abstract][Full Text] [Related]
4. miR-149 represses metastasis of hepatocellular carcinoma by targeting actin-regulatory proteins PPM1F. Luo G; Chao YL; Tang B; Li BS; Xiao YF; Xie R; Wang SM; Wu YY; Dong H; Liu XD; Yang SM Oncotarget; 2015 Nov; 6(35):37808-23. PubMed ID: 26498692 [TBL] [Abstract][Full Text] [Related]
5. Decreased Expression of Fructose-1,6-bisphosphatase Associates with Glucose Metabolism and Tumor Progression in Hepatocellular Carcinoma. Hirata H; Sugimachi K; Komatsu H; Ueda M; Masuda T; Uchi R; Sakimura S; Nambara S; Saito T; Shinden Y; Iguchi T; Eguchi H; Ito S; Terashima K; Sakamoto K; Hirakawa M; Honda H; Mimori K Cancer Res; 2016 Jun; 76(11):3265-76. PubMed ID: 27197151 [TBL] [Abstract][Full Text] [Related]
6. High Expression of Neuropilin-1 Associates with Unfavorable Clinicopathological Features in Hepatocellular Carcinoma. Zhang Y; Liu P; Jiang Y; Dou X; Yan J; Ma C; Fan Q; Wang W; Su F; Tang H; Su X Pathol Oncol Res; 2016 Apr; 22(2):367-75. PubMed ID: 26563279 [TBL] [Abstract][Full Text] [Related]
7. miR-192, a prognostic indicator, targets the SLC39A6/SNAIL pathway to reduce tumor metastasis in human hepatocellular carcinoma. Lian J; Jing Y; Dong Q; Huan L; Chen D; Bao C; Wang Q; Zhao F; Li J; Yao M; Qin L; Liang L; He X Oncotarget; 2016 Jan; 7(3):2672-83. PubMed ID: 26684241 [TBL] [Abstract][Full Text] [Related]
8. Overexpression of annexin A4 indicates poor prognosis and promotes tumor metastasis of hepatocellular carcinoma. Chen W; Chen L; Cai Z; Liang D; Zhao B; Zeng Y; Liu X; Liu J Tumour Biol; 2016 Jul; 37(7):9343-55. PubMed ID: 26779633 [TBL] [Abstract][Full Text] [Related]
9. NKD1 correlates with a poor prognosis and inhibits cell proliferation by inducing p53 expression in hepatocellular carcinoma. Zhang S; Li J; Wang X Tumour Biol; 2016 Oct; 37(10):14059-14067. PubMed ID: 27507614 [TBL] [Abstract][Full Text] [Related]
10. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1. Kan H; Huang Y; Li X; Liu D; Chen J; Shu M Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361 [TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 3 inhibits cell proliferation and serves as a prognostic predictor in hepatocellular carcinoma. Cai J; Yuan SX; Yang F; Tao QF; Yang Y; Xu QG; Wang ZG; Yu J; Lin KY; Wang ZY; Ma JZ; Zhou CC; Wang F; Sun SH; Zhou WP Oncotarget; 2016 Oct; 7(43):70045-70057. PubMed ID: 27661119 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-137 represses FBI-1 to inhibit proliferation and in vitro invasion and migration of hepatocellular carcinoma cells. Zhu M; Li M; Wang T; Linghu E; Wu B Tumour Biol; 2016 Oct; 37(10):13995-14008. PubMed ID: 27492460 [TBL] [Abstract][Full Text] [Related]
14. Hypermethylation of FOXD3 suppresses cell proliferation, invasion and metastasis in hepatocellular carcinoma. He G; Hu S; Zhang D; Wu P; Zhu X; Xin S; Lu G; Ding Y; Liang L Exp Mol Pathol; 2015 Oct; 99(2):374-82. PubMed ID: 26112097 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis. Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251 [TBL] [Abstract][Full Text] [Related]
16. RASSF10 is an epigenetically inactivated tumor suppressor and independent prognostic factor in hepatocellular carcinoma. Wang F; Feng Y; Li P; Wang K; Feng L; Liu YF; Huang H; Guo YB; Mao QS; Xue WJ Oncotarget; 2016 Jan; 7(4):4279-97. PubMed ID: 26701853 [TBL] [Abstract][Full Text] [Related]
17. Overexpression of dishevelled 2 is involved in tumor metastasis and is associated with poor prognosis in hepatocellular carcinoma. Zhang C; Li C; Chen X; Zhou Y; Yin B; Ni R; Zhang Y; Liu J Clin Transl Oncol; 2017 Dec; 19(12):1507-1517. PubMed ID: 28589433 [TBL] [Abstract][Full Text] [Related]
18. Downregulated expression of DIXDC1 in hepatocellular carcinoma and its correlation with prognosis. Zhou S; Shen J; Lin S; Liu X; Xu M; Shi L; Wang X; Cai X Tumour Biol; 2016 Oct; 37(10):13607-13616. PubMed ID: 27468723 [TBL] [Abstract][Full Text] [Related]
19. OTX1 Contributes to Hepatocellular Carcinoma Progression by Regulation of ERK/MAPK Pathway. Li H; Miao Q; Xu CW; Huang JH; Zhou YF; Wu MJ J Korean Med Sci; 2016 Aug; 31(8):1215-23. PubMed ID: 27478331 [TBL] [Abstract][Full Text] [Related]
20. Critical role for the long non-coding RNA AFAP1-AS1 in the proliferation and metastasis of hepatocellular carcinoma. Lu X; Zhou C; Li R; Liang Z; Zhai W; Zhao L; Zhang S Tumour Biol; 2016 Jul; 37(7):9699-707. PubMed ID: 26803513 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]